Skip to content
OpenCapital
Get started

Biohaven BHVN Free cash flow yield

Free cash flow yield at other companies

Eli Lilly logo
Eli LillyLLY
1.4%+0.9pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-5.5%-1.2pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-5.4%-2.2pp
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-31.4%-7.9pp
uniQure logo
uniQureQURE
-16.9%-5.0pp
Roivant Sciences logo
Roivant SciencesROIV
-3.8%-1.5pp

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Calculated from Biohaven’s reported figures.

free cash flow/market cap=-46.7%

Based on trailing twelve months.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's free cash flow yield?
Biohaven (BHVN) reported free cash flow yield of -46.7% in Q1 2026.
How has Biohaven's free cash flow yield changed year-over-year?
Biohaven's free cash flow yield decreased by 76.6% year-over-year, from -26.5% to -46.7%.
What is the long-term trend for Biohaven's free cash flow yield?
Over 3 years (2022 to 2025), Biohaven's free cash flow yield has grown at a 8.3% compound annual growth rate (CAGR), from -32.1% to -40.7%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.